Health and Fitness Health and Fitness
Mon, February 28, 2011
Sun, February 27, 2011
[ Sun, Feb 27th 2011 ] - Market Wire
Sukari Gold Exports
[ Sun, Feb 27th 2011 ] - Market Wire
Athena Field Development
Sat, February 26, 2011
Fri, February 25, 2011

Chemed Corporation to Participate in Panel Discussion at the RBC Capital Marketsa? Healthcare Conference


Published on 2011-02-25 12:55:38 - Market Wire
  Print publication without navigation


CINCINNATI--([ BUSINESS WIRE ])--Chemed Corporation (NYSE:CHE) today announced that it will participate in a corporate panel discussion entitled aThe Opportunities and Challenges of Post-acute Providers in the Future World of Rebundled Reimbursementa at the RBC Capital Marketsa™ Healthcare Conference on Thursday, March 3, 2011. The panel discussion will begin at approximately 8:00 a.m. (ET) at The New York Palace Hotel in New York City. Kevin J. McNamara, President and CEO, will also present an overview of the Company at 9:30 a.m. following the panel discussion.

"The Opportunities and Challenges of Post-acute Providers in the Future World of Rebundled Reimbursement"

The audio webcasts can be accessed by visiting the Chemed website at [ www.chemed.com ] (Investor Relations). The webcast replays will be available within 24 hours after the live presentations and will be accessible for 30 days.

Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation ([ www.chemed.com ]) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care and Roto-Rooter is the nationa™s leading provider of plumbing and drain cleaning services.

Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance.Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances.Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements.Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.